LONG-TERM EFFECTS OF ETANERCEPT TREATMENT ON VASCULAR FUNCTION AND LIPID PARAMETERS IN ANKYLOSING SPONDYLITIS

被引：0
|
作者：
Bodnar, N. [1 ]
Kerekes, G. [2 ]
Vegh, E. [1 ]
Gulyas, K. [1 ]
Balazs, F. [1 ]
Pogacsas, L. [1 ]
Pal, I. [1 ]
Szekanecz, Z. [1 ]
Szanto, S. [1 ]
机构：
[1] Univ Debrecen, Dept Rheumatol, H-4012 Debrecen, Hungary
[2] Univ Debrecen, Inst Med, H-4012 Debrecen, Hungary
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2013年 / 72卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：958 / 958
页数：1
相关论文
共 50 条
  • [31] Long-Term Effects of Comprehensive Inpatient Rehabilitation on Function and Disease Activity in Patients with Chronic Rheumatoid Arthritis and Ankylosing Spondylitis
    Ayhan, Figen
    Gecene, Muharrem
    Gunduz, Rukiye
    Borman, Pinar
    Yorgancioglu, Rezan
    TURKISH JOURNAL OF RHEUMATOLOGY, 2011, 26 (02) : 135 - 144
  • [32] Hodgkin's lymphoma following treatment with etanercept in ankylosing spondylitis
    Aksu, Kenan
    Donmez, Ayhan
    Ertan, Yesim
    Keser, Gokhan
    Inal, Vedat
    Oder, Gonca
    Tombuloglu, Murat
    Kabasakal, Yasemin
    Doganavsargil, Eker
    RHEUMATOLOGY INTERNATIONAL, 2007, 28 (02) : 185 - 187
  • [33] The Treatment of Ankylosing Spondylitis and Psoriatic Arthritis with Etanercept: A Comprehensive Review
    Collamer, Angelique N.
    Battafarano, Daniel F.
    CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2009, 1 : 27 - 43
  • [34] Hodgkin’s lymphoma following treatment with etanercept in ankylosing spondylitis
    Kenan Aksu
    Ayhan Donmez
    Yesim Ertan
    Gokhan Keser
    Vedat Inal
    Gonca Oder
    Murat Tombuloglu
    Yasemin Kabasakal
    Eker Doganavsargil
    Rheumatology International, 2007, 28
  • [35] Immunogenicity does not influence treatment with etanercept in patients with ankylosing spondylitis
    de Vries, M. K.
    van der Horst-Bruinsma, I. E.
    Nurmohamed, M. T.
    Aarden, L. A.
    Stapel, S. O.
    Peters, M. J. L.
    van denderen, J. C.
    Dijkmans, B. A. C.
    Wolbink, G. J.
    ANNALS OF THE RHEUMATIC DISEASES, 2009, 68 (04) : 531 - 535
  • [36] An open-label trial of Etanercept in the treatment of ankylosing spondylitis
    Gorman, JD
    Sack, KE
    Davic, JC
    ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S91 - S91
  • [37] EFFECT OF LONG-TERM TREATMENT WITH SECUKINUMAB ON LIPID PROFILE IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS AND PSORIATIC ARTHRITIS: POOLED 4 YEAR ANALYSIS
    McInnes, Iain
    Gladman, Dafna D.
    Deodhar, Atul
    Richard, Corinne Miceli
    Nash, Peter
    Shete, Abhijit
    Asquith, Daren
    Richards, Hanno
    Pricop, Luminita
    Wang, Jianyuan
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 886 - 887
  • [38] EFFECTS OF LONG-TERM FEEDING OF FRUCTOSE AND GLUCOSE ON LIPID PARAMETERS
    ARD, N
    KOH, ET
    REISER, S
    KNEHANS, A
    FEDERATION PROCEEDINGS, 1984, 43 (04) : 1063 - 1063
  • [39] SICK LEAVE AND ITS PREDICTORS IN ANKYLOSING SPONDYLITIS: LONG-TERM RESULTS FROM THE OUTCOME IN ANKYLOSING SPONDYLITIS INTERNATIONAL STUDY
    Webers, C.
    Ramiro, S.
    Landewe, R.
    van der Heijde, D.
    van den Bosch, F.
    Dougados, M.
    van Tubergen, A.
    Boonen, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 336 - 336
  • [40] AN OPEN LONG-TERM STUDY OF PIROXICAM IN ANKYLOSING-SPONDYLITIS PATIENTS
    SCHATTENKIRCHNER, M
    MULLERFASSBENDER, H
    MELZER, H
    AKTUELLE RHEUMATOLOGIE, 1980, 5 : 38 - 42
12345